Pluristem grabs $55M deal on pulmonary hypertension drugs; Biotech vet Grayson takes Anaphore helm; Vax 'cures' prostate tumors;

@FierceBiotech: Progress seen in 'miracle' line of attack against genetic disorders. Report | Follow @FierceBiotech

@JohnCFierce: It's off to Paris tonight and some sitdowns with the Europeans next week. Still working, though, so keep the tweets and emails coming. Follow @JohnCFierce

> Shares of Pluristem Therapeutics ($PSTI) surged after the biotech reported that it has landed a $55 million deal with United Therapeutics to develop new drugs for pulmonary hypertension. Pluristem gets $7 million of that up front. Story

> Paul Grayson, the former CEO at Fate Therapeutics, is taking the helm at La Jolla, CA-based Anaphore. He's replacing Katherine S. Bowdish, Ph.D., a co-founder of Anaphore, who will continue to serve as a consultant. Anaphore release

> Concert Pharmaceuticals has achieved a $4 million milestone in its strategic alliance with GlaxoSmithKline for its HIV protease inhibitor development program. Concert release

> Science Applications International Corporation says it has won a follow-on contract with the U.S. Army Medical Research and Materiel Command to provide scientific and other support services to the Congressionally Directed Medical Research Programs. Report

@FiercePharma: Pharma marketers band together on social media. Report | Follow @FiercePharma

> Report: Lilly must buy company or be acquired. News

> J&J recalling 40K bottles of Risperdal. Article

> J&J scores win in Levaquin trial. Report

Biotech IT News

> Supercomputing poised for leading R&D role in personalized medicine. Editor's note

> PerkinElmer, others ride 'wave' of genomic data going to the cloud. Report

> AstraZeneca plans tech center in Russia, aims to use informatics to predict drug safety. Story

> Public funds costly for Aussie life sciences supercomputing plan? Article

> Knome automates analysis of NGS data, evolves in genomics field. Report

Medical Device News

> Minnesota students to evaluate Chinese med tech. Report

> Medtronic reports positive results with Valiant. Item

> Philips, ROSATOM ink nuclear medicine MOU. News

> Case against 3M opens in the U.K. Story

> Jan Medical nabs $3.15M in Series A. Article

And Finally...Investigators at the Mayo Clinic and their collaborators in the U.K. say they cured well-established prostate tumors in mice using a human vaccine with no apparent side effects. Release

Suggested Articles

A Roche compound that was designed to treat rheumatoid arthritis could improve the heart's ability to repair itself, a Vanderbilt team found.

After a whirlwind year and two quick-fire raises, cancer startup Black Diamond Therapeutics has nabbed Yumanity, Merck KGaA and SR One veterans to help head up…

In this week's EuroBiotech Report, Lundbeck inks $2 billion Alder buyout, Euro biotechs raise cash and blast rocks Russian smallpox lab.